A novel non-canonical Wnt signature for prostate cancer aggressiveness

scientific article published on 24 December 2016

A novel non-canonical Wnt signature for prostate cancer aggressiveness is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.18632/ONCOTARGET.14161
P932PMC publication ID5354754
P698PubMed publication ID28030815

P50authorTone F. BathenQ61104171
May-Britt TessemQ64706553
Finn DrabløsQ43415197
P2093author name stringAlan J Wright
Trond Viset
Ailin Falkmo Hansen
Anna M Bofin
Elin Richardsen
Elise Sandsmark
Helena Bertilsson
Kirsten M Selnæs
Morten B Rye
P2860cites workThe clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dotsQ21093286
Wnt signaling pathways in urological cancers: past decades and still growingQ21245761
Hallmarks of Cancer: The Next GenerationQ22252312
A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasisQ24307454
Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradationQ24319714
Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinomaQ24336272
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profilesQ24536351
The basics of epithelial-mesenchymal transitionQ24652992
Wnt/β-catenin signalling in prostate cancerQ28269116
Elevated level of Wnt5a protein in localized prostate cancer tissue is associated with better outcomeQ28477590
Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomyQ28534277
Emphasizing the role of Wnt5a protein expression to predict favorable outcome after radical prostatectomy in patients with low-grade prostate cancerQ28709995
WNT signalling pathways as therapeutic targets in cancerQ29615666
Integrative genomic profiling of human prostate cancerQ29619905
Integrative molecular concept modeling of prostate cancer progression.Q33266777
Estimation of metabolite concentrations from localized in vivo proton NMR spectraQ72319396
Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancerQ73937761
Molecular sampling of prostate cancer: a dilemma for predicting disease progressionQ33541296
In silico estimates of tissue components in surgical samples based on expression profiling dataQ33642598
Challenging role of Wnt5a and its signaling pathway in cancer metastasis (Review).Q33769672
Wnt signaling in cancerQ34262857
Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiationQ34458518
Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressivenessQ34693066
Gene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancerQ35223291
Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanismsQ35609965
Molecular classification of prostate cancer using curated expression signaturesQ35641563
A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate CancerQ35996026
Wnt signalling and prostate cancerQ36089054
Roles and regulation of Wnt signaling and beta-catenin in prostate cancerQ36197343
Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferationQ37086749
Discovery and characterization of a small molecule inhibitor of the PDZ domain of dishevelled.Q37269189
The opposing roles of Wnt-5a in cancerQ37551599
Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 inductionQ37650625
Interplay of cadherin-mediated cell adhesion and canonical Wnt signalingQ37698281
Wnt signalling and the control of cellular metabolism.Q37708317
WNT signaling: an emerging mediator of cancer cell metabolism?Q38263093
Role of epithelial mesenchymal transition in prostate tumorigenesisQ38288544
Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.Q38446601
WNT5A-mediated β-catenin-independent signalling is a novel regulator of cancer cell metabolismQ38628775
WNT5A has anti-prostate cancer effects in vitro and reduces tumor growth in the skeleton in vivoQ38956252
Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signalingQ39092267
Polyamines modulate epithelial-to-mesenchymal transitionQ39477470
Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinaseQ39747925
Wnt3a growth factor induces androgen receptor-mediated transcription and enhances cell growth in human prostate cancer cells.Q40479983
Activation of β-catenin signaling in androgen receptor-negative prostate cancer cellsQ40834731
A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancerQ42522113
WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristicsQ46051855
Spatially matched in vivo and ex vivo MR metabolic profiles of prostate cancer -- investigation of a correlation with Gleason scoreQ46956034
Changes in gene transcription underlying the aberrant citrate and choline metabolism in human prostate cancer samplesQ47892665
Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic featuresQ48561667
A new method to provide a fresh frozen prostate slice suitable for gene expression study and MR spectroscopyQ57185246
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectprostate cancerQ181257
P304page(s)9572-9586
P577publication date2016-12-24
P1433published inOncotargetQ1573155
P1476titleA novel non-canonical Wnt signature for prostate cancer aggressiveness
P478volume8

Reverse relations

cites work (P2860)
Q90146243Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling
Q100490624Emerging role of tumor cell plasticity in modifying therapeutic response
Q98154696Epigenetic analysis identifies factors driving racial disparity in prostate cancer
Q50260314Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
Q87828465Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
Q93200972Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases
Q90599306FZD2 regulates cell proliferation and invasion in tongue squamous cell carcinoma
Q61796260Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer
Q64230297Metabolomics Biomarkers of Prostate Cancer: A Systematic Review
Q62555115Polyamine metabolism and cancer: treatments, challenges and opportunities
Q64114067RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer
Q45723424SFRP4 gene expression is increased in aggressive prostate cancer
Q47112301The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression
Q41491922Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model.
Q47818549WNT signalling in prostate cancer.
Q49578198WNT5A induces castration-resistant prostate cancer via CCL2 and tumour-infiltrating macrophages
Q90687151Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion
Q92783226Wnt Signaling Pathways in Keratinocyte Carcinomas

Search more.